PubMed · 2026

Randomized Phase 2b Trial of CBL-514 Injection for Abdominal Subcutaneous Fat Reduction With Clinician- and Patient-reported Outcomes and MRI Assessment

Lorenc ZP, Gold M, Schlessinger J, Lain ET, et al. (2026). Randomized Phase 2b Trial of CBL-514 Injection for Abdominal Subcutaneous Fat Reduction With Clinician- and Patient-reported Outcomes and MRI Assessment. Aesthetic Surgery Journal.

Aesthetic Surgery Journal

Source: https://pubmed.ncbi.nlm.nih.gov/42159040/

Last reviewed . By the PeptIQ team.

Peptides linked in PeptIQ Wiki

This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.